PartitionBio

PartitionBio is a biotechnology company developing a non-viral intracellular delivery platform based on biomolecular condensates formed through liquid-liquid phase separation.

The platform enables delivery of a broad range of macromolecular cargos including nucleic acids, proteins, and gene-editing complexes across diverse cell types, including hard-to-transfect primary and stem cells.

Applications span gene therapy, RNA and DNA delivery, functional genomics, and protein delivery.